|
| | 97TH GENERAL ASSEMBLY
State of Illinois
2011 and 2012 HB5250 Introduced 2/8/2012, by Rep. William Cunningham SYNOPSIS AS INTRODUCED: |
|
720 ILCS 570/401 | from Ch. 56 1/2, par. 1401 |
|
Amends the Illinois Controlled Substances Act. Provides for enhanced penalties for the manufacturing or delivery, or possession with intent to
manufacture or deliver, of any substance containing hydrocodone, dihydrocodeinone, dihydrocodeine, oxycodone, or any of the salts, isomers and salts of isomers, or analog of those substances.
|
| |
| | | CORRECTIONAL BUDGET AND IMPACT NOTE ACT MAY APPLY | |
| | A BILL FOR |
|
|
| | HB5250 | | LRB097 18577 RLC 63809 b |
|
|
1 | | AN ACT concerning criminal law.
|
2 | | Be it enacted by the People of the State of Illinois,
|
3 | | represented in the General Assembly:
|
4 | | Section 5. The Illinois Controlled Substances Act is |
5 | | amended by changing Section 401 as follows:
|
6 | | (720 ILCS 570/401) (from Ch. 56 1/2, par. 1401)
|
7 | | Sec. 401. Except as authorized by this Act, it is unlawful |
8 | | for any
person knowingly to manufacture or deliver, or possess |
9 | | with intent to
manufacture or deliver, a controlled substance |
10 | | other than methamphetamine, a counterfeit substance, or a |
11 | | controlled
substance analog. A violation of this Act with |
12 | | respect to each of the controlled
substances listed herein |
13 | | constitutes a single and separate violation of this
Act. For |
14 | | purposes of this Section, "controlled substance analog" or |
15 | | "analog"
means a substance
which is intended for human |
16 | | consumption, other than a controlled substance,
that has a |
17 | | chemical structure substantially similar to that of a |
18 | | controlled
substance in Schedule I or II, or that was |
19 | | specifically designed to produce
an effect substantially |
20 | | similar to that of a controlled substance in Schedule
I or II. |
21 | | Examples of chemical classes in which controlled substance |
22 | | analogs
are found include, but are not limited to, the |
23 | | following: phenethylamines,
N-substituted piperidines, |
|
| | HB5250 | - 2 - | LRB097 18577 RLC 63809 b |
|
|
1 | | morphinans, ecgonines, quinazolinones, substituted
indoles, |
2 | | and arylcycloalkylamines. For purposes of this Act, a |
3 | | controlled
substance analog shall be treated in the same manner |
4 | | as the controlled
substance to which it is substantially |
5 | | similar.
|
6 | | (a) Any person who violates this Section with respect to |
7 | | the following
amounts of controlled or counterfeit substances |
8 | | or controlled substance
analogs, notwithstanding any of the |
9 | | provisions of subsections (c),
(d), (e), (f), (g) or (h) to the |
10 | | contrary, is guilty of a Class X felony
and shall be sentenced |
11 | | to a term of imprisonment as provided in this subsection
(a) |
12 | | and fined as provided in subsection (b):
|
13 | | (1) (A) not less than 6 years and not more than 30 |
14 | | years with respect
to 15 grams or more but less than |
15 | | 100 grams of a substance containing
heroin, or an |
16 | | analog thereof;
|
17 | | (B) not less than 9 years and not more than 40 |
18 | | years with respect to 100
grams or more but less than |
19 | | 400 grams of a substance containing heroin, or
an |
20 | | analog thereof;
|
21 | | (C) not less than 12 years and not more than 50 |
22 | | years with respect to
400 grams or more but less than |
23 | | 900 grams of a substance containing heroin,
or an |
24 | | analog thereof;
|
25 | | (D) not less than 15 years and not more than 60 |
26 | | years with respect to
900 grams or more of any |
|
| | HB5250 | - 3 - | LRB097 18577 RLC 63809 b |
|
|
1 | | substance containing heroin, or an analog thereof;
|
2 | | (1.5) (A) not less than 6 years and not more than 30 |
3 | | years with respect to 15 grams or more but less than |
4 | | 100 grams of a substance containing fentanyl, or an |
5 | | analog thereof;
|
6 | | (B) not less than 9 years and not more than 40 |
7 | | years with respect to 100 grams or more but less than |
8 | | 400 grams of a substance containing fentanyl, or an |
9 | | analog thereof; |
10 | | (C) not less than 12 years and not more than 50 |
11 | | years with respect to 400 grams or more but less than |
12 | | 900 grams of a substance containing fentanyl, or an |
13 | | analog thereof; |
14 | | (D) not less than 15 years and not more than 60 |
15 | | years with respect to 900 grams or more of a substance |
16 | | containing fentanyl, or an analog thereof;
|
17 | | (2) (A) not less than 6 years and not more than 30 |
18 | | years with respect
to 15 grams or more but less than |
19 | | 100 grams of a substance containing
cocaine, or an |
20 | | analog thereof;
|
21 | | (B) not less than 9 years and not more than 40 |
22 | | years with respect to 100
grams or more but less than |
23 | | 400 grams of a substance containing cocaine, or
an |
24 | | analog thereof;
|
25 | | (C) not less than 12 years and not more than 50 |
26 | | years with respect to
400 grams or more but less than |
|
| | HB5250 | - 4 - | LRB097 18577 RLC 63809 b |
|
|
1 | | 900 grams of a substance containing cocaine,
or an |
2 | | analog thereof;
|
3 | | (D) not less than 15 years and not more than 60 |
4 | | years with respect to
900 grams or more of any |
5 | | substance containing cocaine, or an analog thereof;
|
6 | | (3) (A) not less than 6 years and not more than 30 |
7 | | years with respect
to 15 grams or more but less than |
8 | | 100 grams of a substance containing
morphine, or an |
9 | | analog thereof;
|
10 | | (B) not less than 9 years and not more than 40 |
11 | | years with respect to
100 grams or more but less than |
12 | | 400 grams of a substance containing morphine,
or an |
13 | | analog thereof;
|
14 | | (C) not less than 12 years and not more than 50 |
15 | | years with respect to
400 grams or more but less than |
16 | | 900 grams of a substance containing
morphine, or an |
17 | | analog thereof;
|
18 | | (D) not less than 15 years and not more than 60 |
19 | | years with respect to
900 grams or more of a substance |
20 | | containing morphine, or an analog thereof;
|
21 | | (4) 200 grams or more of any substance containing |
22 | | peyote, or an
analog thereof;
|
23 | | (5) 200 grams or more of any substance containing a |
24 | | derivative of
barbituric acid or any of the salts of a |
25 | | derivative of barbituric acid, or
an analog thereof;
|
26 | | (6) 200 grams or more of any substance containing |
|
| | HB5250 | - 5 - | LRB097 18577 RLC 63809 b |
|
|
1 | | amphetamine
or any salt of an optical isomer of |
2 | | amphetamine,
or an analog thereof;
|
3 | | (6.5) (blank);
|
4 | | (6.6) (blank);
|
5 | | (7) (A) not less than 6 years and not more than 30 |
6 | | years with respect
to: (i) 15 grams or more but less |
7 | | than 100 grams of a substance containing
lysergic acid |
8 | | diethylamide (LSD), or an analog thereof, or (ii) 15 or
|
9 | | more objects or 15 or more segregated parts of an |
10 | | object or objects but
less than 200 objects or 200 |
11 | | segregated parts of an object or objects
containing in |
12 | | them or having upon them any amounts of any substance
|
13 | | containing lysergic acid diethylamide (LSD), or an |
14 | | analog thereof;
|
15 | | (B) not less than 9 years and not more than 40 |
16 | | years with respect
to: (i) 100 grams or more but less |
17 | | than 400 grams of a substance containing
lysergic acid |
18 | | diethylamide (LSD), or an analog thereof, or (ii) 200 |
19 | | or more
objects or 200 or more segregated parts of an |
20 | | object or objects but less
than 600 objects or less |
21 | | than 600 segregated parts of an object or objects
|
22 | | containing in them or having upon them any amount of |
23 | | any substance
containing lysergic acid diethylamide |
24 | | (LSD), or an analog thereof;
|
25 | | (C) not less than 12 years and not more than 50 |
26 | | years with respect
to: (i) 400 grams or more but less |
|
| | HB5250 | - 6 - | LRB097 18577 RLC 63809 b |
|
|
1 | | than 900 grams of a substance containing
lysergic acid |
2 | | diethylamide (LSD), or an analog thereof, or (ii) 600 |
3 | | or more
objects or 600 or more segregated parts of an |
4 | | object or objects but less
than 1500 objects or 1500 |
5 | | segregated parts of an object or objects
containing in |
6 | | them or having upon them any amount of any substance
|
7 | | containing lysergic acid diethylamide (LSD), or an |
8 | | analog thereof;
|
9 | | (D) not less than 15 years and not more than 60 |
10 | | years with respect
to: (i) 900 grams or more of any |
11 | | substance containing lysergic acid
diethylamide (LSD), |
12 | | or an analog thereof, or (ii) 1500 or more objects or
|
13 | | 1500 or more segregated parts of an object or objects |
14 | | containing in them or
having upon them any amount of a |
15 | | substance containing lysergic acid
diethylamide (LSD), |
16 | | or an analog thereof;
|
17 | | (7.5) (A) not less than 6 years and not more than 30 |
18 | | years with respect
to:
(i) 15
grams or more but less |
19 | | than 100 grams of a substance listed in paragraph (1),
|
20 | | (2), (2.1), (2.2), (3), (14.1), (19), (20), (20.1), |
21 | | (21), (25), or (26) of subsection
(d) of Section 204, |
22 | | or an analog or derivative thereof, or (ii) 15 or more
|
23 | | pills, tablets, caplets, capsules, or objects but less |
24 | | than 200 pills, tablets,
caplets, capsules, or objects |
25 | | containing in them or having upon them any
amounts of |
26 | | any substance listed in paragraph (1), (2), (2.1), |
|
| | HB5250 | - 7 - | LRB097 18577 RLC 63809 b |
|
|
1 | | (2.2), (3), (14.1),
(19), (20), (20.1), (21), (25), or |
2 | | (26) of subsection (d) of Section 204, or
an analog or |
3 | | derivative thereof;
|
4 | | (B) not less than 9 years and not more than 40 |
5 | | years with respect to:
(i) 100 grams or more but less |
6 | | than 400 grams of a substance listed in
paragraph (1), |
7 | | (2), (2.1), (2.2), (3), (14.1), (19), (20),
(20.1), |
8 | | (21), (25), or (26) of subsection (d) of Section 204, |
9 | | or an analog or
derivative thereof, or (ii) 200 or more |
10 | | pills, tablets, caplets, capsules, or
objects but less |
11 | | than 600 pills, tablets, caplets, capsules, or objects
|
12 | | containing in them or having upon them any amount of |
13 | | any substance listed in
paragraph (1), (2), (2.1), |
14 | | (2.2), (3), (14.1), (19), (20), (20.1), (21), (25), or |
15 | | (26)
of subsection (d) of Section 204, or an analog or |
16 | | derivative thereof;
|
17 | | (C) not less than 12 years and not more than 50 |
18 | | years with respect to:
(i) 400 grams or more but less |
19 | | than 900 grams of a substance listed in
paragraph (1), |
20 | | (2), (2.1), (2.2), (3), (14.1), (19), (20), (20.1), |
21 | | (21), (25), or (26)
of subsection (d) of Section 204, |
22 | | or an analog or derivative thereof,
or (ii) 600 or more |
23 | | pills, tablets, caplets, capsules, or objects but less |
24 | | than
1,500 pills, tablets, caplets, capsules, or |
25 | | objects
containing in them or having upon them any |
26 | | amount of any substance listed in
paragraph (1), (2), |
|
| | HB5250 | - 8 - | LRB097 18577 RLC 63809 b |
|
|
1 | | (2.1), (2.2), (3), (14.1), (19), (20), (20.1), (21), |
2 | | (25), or (26)
of subsection (d) of Section 204, or an |
3 | | analog or derivative thereof;
|
4 | | (D) not less than 15 years and not more than 60 |
5 | | years with respect to:
(i) 900 grams or more of any |
6 | | substance listed in paragraph (1), (2), (2.1),
(2.2), |
7 | | (3), (14.1), (19), (20), (20.1), (21), (25), or (26) of |
8 | | subsection (d) of
Section 204, or an analog or |
9 | | derivative thereof, or (ii) 1,500 or more pills,
|
10 | | tablets, caplets, capsules, or objects containing in |
11 | | them or having upon them
any amount
of a substance |
12 | | listed in paragraph (1), (2), (2.1), (2.2), (3), |
13 | | (14.1), (19),
(20), (20.1), (21), (25), or (26)
of |
14 | | subsection (d) of Section 204, or an analog or |
15 | | derivative thereof;
|
16 | | (8) 30 grams or more of any substance containing |
17 | | pentazocine or any of
the salts, isomers and salts of |
18 | | isomers of pentazocine, or an analog thereof;
|
19 | | (9) 30 grams or more of any substance containing |
20 | | methaqualone or any of
the salts, isomers and salts of |
21 | | isomers of methaqualone, or an analog thereof;
|
22 | | (10) 30 grams or more of any substance containing |
23 | | phencyclidine or any
of the salts, isomers and salts of |
24 | | isomers of phencyclidine (PCP),
or an analog thereof;
|
25 | | (10.5) 30 grams or more of any substance containing |
26 | | ketamine
or any of the salts, isomers and salts of isomers |
|
| | HB5250 | - 9 - | LRB097 18577 RLC 63809 b |
|
|
1 | | of ketamine,
or an analog thereof;
|
2 | | (10.6) 100 grams or more of any substance containing |
3 | | hydrocodone, or any of the salts, isomers and salts of |
4 | | isomers of hydrocodone, or an analog thereof; |
5 | | (10.7) 100 grams or more of any substance containing |
6 | | dihydrocodeinone, or any of the salts, isomers and salts of |
7 | | isomers of dihydrocodeinone, or an analog thereof; |
8 | | (10.8) 100 grams or more of any substance containing |
9 | | dihydrocodeine, or any of the salts, isomers and salts of |
10 | | isomers of dihydrocodeine, or an analog thereof; |
11 | | (10.9) 100 grams or more of any substance containing |
12 | | oxycodone, or any of the salts, isomers and salts of |
13 | | isomers of oxycodone, or an analog thereof;
|
14 | | (11) 200 grams or more of any substance containing any |
15 | | other controlled
substance classified in Schedules I or II, |
16 | | or an analog thereof, which is
not otherwise included in |
17 | | this subsection.
|
18 | | (b) Any person sentenced with respect to violations of |
19 | | paragraph (1),
(2), (3), (7), or (7.5) of subsection (a) |
20 | | involving
100 grams or
more of the
controlled substance named |
21 | | therein, may in addition to the penalties
provided therein, be |
22 | | fined an amount not more than $500,000 or the full
street value |
23 | | of the controlled or counterfeit substance or controlled |
24 | | substance
analog, whichever is greater. The term "street value" |
25 | | shall have the
meaning ascribed in Section 110-5 of the Code of |
26 | | Criminal Procedure of
1963. Any person sentenced with respect |
|
| | HB5250 | - 10 - | LRB097 18577 RLC 63809 b |
|
|
1 | | to any other provision of
subsection (a), may in addition to |
2 | | the penalties provided therein, be fined
an amount not to |
3 | | exceed $500,000. |
4 | | (b-1) Excluding violations of this Act when the controlled |
5 | | substance is fentanyl, any person sentenced to a term of |
6 | | imprisonment with respect to violations of Section 401, 401.1, |
7 | | 405, 405.1, 405.2, or 407, when the substance containing the |
8 | | controlled substance contains any amount of fentanyl, 3 years |
9 | | shall be added to the term of imprisonment imposed by the |
10 | | court, and the maximum sentence for the offense shall be |
11 | | increased by 3 years.
|
12 | | (c) Any person who violates this Section with regard to the
|
13 | | following amounts of controlled or counterfeit substances
or |
14 | | controlled substance analogs, notwithstanding any of the |
15 | | provisions of
subsections (a), (b), (d), (e), (f), (g) or (h) |
16 | | to the
contrary, is guilty of a Class 1 felony. The fine for |
17 | | violation of this
subsection (c) shall not be more than |
18 | | $250,000:
|
19 | | (1) 1 gram or more but less than 15 grams of any
|
20 | | substance containing heroin, or an analog thereof;
|
21 | | (1.5) 1 gram or more but less than 15 grams of any |
22 | | substance containing fentanyl, or an analog thereof;
|
23 | | (2) 1 gram or more but less than 15
grams of any |
24 | | substance containing cocaine, or an analog thereof;
|
25 | | (3) 10 grams or more but less than 15 grams of any |
26 | | substance
containing morphine, or an analog thereof;
|
|
| | HB5250 | - 11 - | LRB097 18577 RLC 63809 b |
|
|
1 | | (4) 50 grams or more but less than 200 grams of any |
2 | | substance
containing peyote, or an analog thereof;
|
3 | | (5) 50 grams or more but less than 200 grams of any |
4 | | substance
containing a derivative of barbituric acid or any |
5 | | of the salts of a
derivative of barbituric acid, or an |
6 | | analog thereof;
|
7 | | (6) 50 grams or more but less than 200 grams of any |
8 | | substance
containing amphetamine or any salt of an optical |
9 | | isomer
of amphetamine, or an analog thereof;
|
10 | | (6.5) (blank);
|
11 | | (7) (i) 5 grams or more but less than 15 grams of any |
12 | | substance
containing lysergic acid diethylamide (LSD), or |
13 | | an analog thereof,
or (ii)
more than 10 objects or more |
14 | | than 10 segregated parts of an object or objects
but less |
15 | | than 15 objects or less than 15 segregated parts of an |
16 | | object
containing in them or having upon them any amount of |
17 | | any substance
containing lysergic acid diethylamide (LSD), |
18 | | or an analog thereof;
|
19 | | (7.5) (i) 5 grams or more but less than 15 grams of any |
20 | | substance listed
in paragraph (1), (2), (2.1), (2.2), (3), |
21 | | (14.1), (19), (20), (20.1), (21), (25), or
(26) of |
22 | | subsection (d) of Section 204, or an analog or derivative |
23 | | thereof, or
(ii) more than 10 pills, tablets, caplets, |
24 | | capsules, or objects but less than
15 pills, tablets, |
25 | | caplets, capsules, or objects containing in them or having
|
26 | | upon them any amount of any substance listed in paragraph |
|
| | HB5250 | - 12 - | LRB097 18577 RLC 63809 b |
|
|
1 | | (1), (2), (2.1),
(2.2), (3), (14.1), (19), (20), (20.1), |
2 | | (21), (25), or (26) of subsection (d) of
Section 204, or an |
3 | | analog or derivative thereof;
|
4 | | (8) 10 grams or more but less than 30 grams of any |
5 | | substance
containing pentazocine or any of the salts, |
6 | | isomers and salts of isomers of
pentazocine, or an analog |
7 | | thereof;
|
8 | | (9) 10 grams or more but less than 30 grams of any |
9 | | substance
containing methaqualone or any of the salts, |
10 | | isomers and salts of isomers
of methaqualone, or an analog |
11 | | thereof;
|
12 | | (10) 10 grams or more but less than 30 grams of any |
13 | | substance
containing phencyclidine or any of the salts, |
14 | | isomers and salts of isomers
of phencyclidine (PCP), or an |
15 | | analog thereof;
|
16 | | (10.5) 10 grams or more but less than 30 grams of any |
17 | | substance
containing ketamine or any of the salts, isomers |
18 | | and salts of
isomers of ketamine, or an analog thereof;
|
19 | | (10.6) 50 grams or more but less than 100 grams of any |
20 | | substance containing hydrocodone, or any of the salts, |
21 | | isomers and salts of isomers of hydrocodone, or an analog |
22 | | thereof; |
23 | | (10.7) 50 grams or more but less than 100 grams of any |
24 | | substance containing dihydrocodeinone, or any of the |
25 | | salts, isomers and salts of isomers of dihydrocodeinone, or |
26 | | an analog thereof; |
|
| | HB5250 | - 13 - | LRB097 18577 RLC 63809 b |
|
|
1 | | (10.8) 50 grams or more but less than 100 grams of any |
2 | | substance containing dihydrocodeine, or any of the salts, |
3 | | isomers and salts of isomers of dihydrocodeine, or an |
4 | | analog thereof; |
5 | | (10.9) 50 grams or more but less than 100 grams of any |
6 | | substance containing oxycodone, or any of the salts, |
7 | | isomers and salts of isomers of oxycodone, or an analog |
8 | | thereof;
|
9 | | (11) 50 grams or more but less than 200 grams of any |
10 | | substance
containing a substance classified in Schedules I |
11 | | or II, or an analog
thereof, which is not otherwise |
12 | | included in this subsection.
|
13 | | (c-5) (Blank).
|
14 | | (d) Any person who violates this Section with regard to any |
15 | | other
amount of a controlled or counterfeit substance |
16 | | containing dihydrocodeinone or dihydrocodeine or classified in
|
17 | | Schedules I or II, or an analog thereof, which is (i) a |
18 | | narcotic
drug, (ii) lysergic acid diethylamide (LSD) or an |
19 | | analog thereof,
(iii) any
substance containing amphetamine or |
20 | | fentanyl or any salt or optical
isomer of amphetamine or |
21 | | fentanyl, or an analog thereof, or (iv) any
substance |
22 | | containing N-Benzylpiperazine (BZP) or any salt or optical
|
23 | | isomer of N-Benzylpiperazine (BZP), or an analog thereof, is |
24 | | guilty
of a Class 2 felony. The fine for violation of this |
25 | | subsection (d) shall
not be more than $200,000.
|
26 | | (d-5) (Blank).
|
|
| | HB5250 | - 14 - | LRB097 18577 RLC 63809 b |
|
|
1 | | (e) Any person who violates this Section with regard to any |
2 | | other
amount of a controlled substance other than |
3 | | methamphetamine or counterfeit substance classified in
|
4 | | Schedule I or II, or an analog thereof, which substance is not
|
5 | | included under subsection (d) of this Section, is
guilty of a |
6 | | Class 3 felony. The fine for violation of this subsection (e)
|
7 | | shall not be more than $150,000.
|
8 | | (f) Any person who violates this Section with regard to any |
9 | | other
amount of a controlled or counterfeit substance |
10 | | classified in
Schedule III is guilty of a Class 3 felony. The |
11 | | fine for violation of
this subsection (f) shall not be more |
12 | | than $125,000.
|
13 | | (g) Any person who violates this Section with regard to any |
14 | | other
amount of a controlled or counterfeit substance |
15 | | classified
in Schedule IV is guilty of a Class 3 felony. The |
16 | | fine for violation of
this subsection (g) shall not be more |
17 | | than $100,000.
|
18 | | (h) Any person who violates this Section with regard to any |
19 | | other
amount of a controlled or counterfeit substance |
20 | | classified in
Schedule V is guilty of a Class 3 felony. The |
21 | | fine for violation of this
subsection (h) shall not be more |
22 | | than $75,000.
|
23 | | (i) This Section does not apply to the manufacture, |
24 | | possession or
distribution of a substance in conformance with |
25 | | the provisions of an approved
new drug application or an |
26 | | exemption for investigational use within the
meaning of Section |